BioCentury
ARTICLE | Financial News

M3 raises $10M in series A

February 12, 2016 2:27 AM UTC

M3 Biotechnology Inc. (Seattle, Wash.) raised $10 million in an oversubscribed series A round. Brothers Bruce and Michael Montgomery invested alongside W-Fund, WRF Capital, John Fluke and Dolby Family Ventures.

CEO Leen Kawas told BioCentury the company plans to begin clinical studies by YE16 of lead candidate MM-201, an oral small molecule mimetic of a neurotrophic factor to treat neurodegenerative diseases. ...